The Food and Drug Administration is altering its stance on the safety and efficacy of generic prescription drugs after problems arose with a popular, extended-release generic antidepressant drug. According to a New York Times report, problems with the 300-milligram dose of bupropion have prompted health officials to look at how they … [Read more...] about FDA altering stance on generic prescription drugs